Mercury Laboratories Ltd (538964) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 538964 | NSE: | Pharmaceuticals & Drugs | Small Cap

Mercury Laboratories Share Price

860.20 -12.60 -1.44%
as on 05-Dec'25 12:08

Mercury Laboratories Ltd (538964) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 538964 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Mercury Laboratories

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Mercury Laboratories stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
21.32
Market Cap:
104.7 Cr.
52-wk low:
736
52-wk high:
1,005

Is Mercury Laboratories Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Mercury Laboratories: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Mercury Laboratories Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 21.6%18.9%9.9%13.8%13.3%20.6%12.3%16.2%13.6%9.1%-
Value Creation
Index
0.50.4-0.30.0-0.10.5-0.10.20.0-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 47.54851.955.557.368.657.975.375.675.177
Sales YoY Gr.-1.1%8%7%3.2%19.8%-15.6%30.1%0.3%-0.6%-
Adj EPS 30.323.616.820.726.242.926.339.344.723.340.9
YoY Gr.--22.3%-28.7%23.2%26.5%63.6%-38.7%49.3%13.7%-47.8%-
BVPS (₹) 182.1203.9219.6241.4266.5307.5335.9380.2423.7446.4464.7
Adj Net
Profit
3.62.822.53.15.13.24.75.42.85
Cash Flow from Ops. -0.11.955.25.58.25.22.58.24-
Debt/CF from Ops. -763.921.81.30.912.20.71-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 5.2%5.6%9%-0.6%
Adj EPS -2.9%-2.3%-3.9%-47.8%
BVPS10.5%10.9%10%5.4%
Share Price 3.9% 11.9% 2.4% -12%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
18.212.27.9910.314.98.21111.15.49
Op. Profit
Mgn %
13.614.48.510.310.81412.111.4129.311.1
Net Profit
Mgn %
7.75.93.94.55.57.55.56.37.13.76.4
Debt to
Equity
0.30.30.40.30.20.20.10.10.10.10.1
Working Cap
Days
17721020119219617120115015517092
Cash Conv.
Cycle
577284727664878410010262

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Mercury Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 40.9 -
TTM Sales (₹ Cr.) 77.4 -
BVPS (₹.) 464.7 -
Reserves (₹ Cr.) 55 -
P/BV 1.88 -
PE 21.32 -
From the Market
52 Week Low / High (₹) 736.00 / 1005.00
All Time Low / High (₹) 32.49 / 1303.00
Market Cap (₹ Cr.) 105
Equity (₹ Cr.) 1.2
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Mercury Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Mercury Laboratories - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Mercury Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales48485256576958757675
Operating Expenses 41414750515951676768
Manufacturing Costs991111111411161415
Material Costs13141619172115192018
Employee Cost 777891012141416
Other Costs 12121412131512181819
Operating Profit 67466107997
Operating Profit Margin (%) 13.6%14.0%8.4%10.3%10.8%14.0%12.1%11.4%12.0%9.3%
Other Income 1001111211
Interest 1111110001
Depreciation 1112222233
Exceptional Items 0000000000
Profit Before Tax 5524485775
Tax 1201131212
Profit After Tax 4323354663
PAT Margin (%) 8.3%5.6%3.9%5.1%5.6%7.8%6.1%7.4%7.5%4.2%
Adjusted EPS (₹)32.722.516.823.626.944.529.746.547.126.2
Dividend Payout Ratio (%)5%7%9%6%7%8%12%8%7%13%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 22242629323740465154
Share Capital 1111111111
Reserves 21232528313639445052
Minority Interest0000000000
Debt77109665554
Long Term Debt37109662233
Short Term Debt4000003321
Trade Payables81091281276510
Others Liabilities 11978101010777
Total Liabilities 47515257566562646874

Fixed Assets

Gross Block25263035374143444648
Accumulated Depreciation78911131517202224
Net Fixed Assets 19182124242626242425
CWIP 0000000049
Investments 0000000000
Inventories6887657767
Trade Receivables13181519182317212226
Cash Equivalents 1141357782
Others Assets 7645666445
Total Assets 47515257566562646874

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0255585284
PBT 5524485775
Adjustment 2223333333
Changes in Working Capital -5-41-1-0-1-1-7-1-2
Tax Paid -1-1-1-1-1-1-2-1-1-2
Cash Flow From Investing Activity -0-2-4-5-1-5-2-1-6-9
Capex -0-2-4-5-1-5-2-1-6-9
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 0-01-3-3-1-1-1-1-1
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 1-12-1-2-0-1-000
Interest Paid 0-1-1-1-1-1-0-0-0-1
Dividend Paid -0-0-0-0-0-0-0-0-0-0
Others -01-0-0-0-01-0-1-0
Net Cash Flow 002-212201-6

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)19.6211.677.9210.2610.5915.59.2312.9811.726.02
ROCE (%)21.5818.939.8913.7713.2520.5612.2616.1913.619.14
Asset Turnover Ratio1.131.031.021.021.011.130.911.191.141.06
PAT to CFO Conversion(x)-00.672.51.671.671.61.250.331.331.33
Working Capital Days
Receivable Days9311311211211910812492104116
Inventory Days39515348392838333233
Payable Days207240222200211178226128104153

Mercury Laboratories Ltd Stock News

Mercury Laboratories Ltd FAQs

The current trading price of Mercury Laboratories on 05-Dec-2025 12:08 is ₹860.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Mercury Laboratories stood at ₹104.7.
The latest P/E ratio of Mercury Laboratories as of 04-Dec-2025 is 21.32.
The latest P/B ratio of Mercury Laboratories as of 04-Dec-2025 is 1.88.
The 52-week high of Mercury Laboratories is ₹1,005 and the 52-week low is ₹736.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mercury Laboratories is ₹77.38 ( Cr.) .

About Mercury Laboratories Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×